Heating & Chilling Laboratory Equipment
October 13, 2014
Carlsbad,CA -- Torrey Pines Scientific, Inc®. announces its new line of multi-position analog stirring hot plates and stirrers featuring 5 or 9 stirring positions. The large 12” (305 mm) square ceramic heater tops have a temperature range to 450°C. The 5-position stirring units can stir 5-800ml beakers, and the 9-position units can stir 9-500ml beakers [...]
BD Acquires GenCell Biosystems
October 13, 2014
FRANKLIN LAKES, N.J.-- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications. "We [...]
RainDanceTechnologiesAppointsJohnA.LuckeyVicePresidentofProductDevelopment
October 10, 2014
BILLERICA, Mass. — — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of John Luckey, Ph.D., as its new Vice President of Product Development. Dr. Luckey brings more than 20 years of experience leading teams tasked with developing biotechnology systems and technology platforms. During his [...]
Process up to 12 Western Blots Simultaneously with Precise Reproducibility
October 10, 2014
MANSFIELD, MA – “The functional simplicity of the BlotCycler™ design is convincing researchers that the time for automating their western blot assays is here,” says Russ Yukhananov, Ph.D., CEO of Precision Biosystems. BlotCycler™ delivers an affordable solution for busy labs demanding reproducible results. By reducing variables from slight variations in fluid delivery, timing and washing [...]
DNASTAR Lasergene 12.1 Software Integrates Cloud Capability with Ground Computers
October 10, 2014
MADISON, Wisconsin –– DNASTAR® announced the release of Lasergene 12.1 today, representing a major advancement in integrating traditional Lasergene desktop computer software with advanced capabilities on the cloud. Genomic scientists can now run multiple sequence assemblies on the cloud simultaneously without the need to invest in a large compute cluster. Lasergene 12.1 also introduces the [...]
October 10, 2014
JENA/Germany -- ZEISS congratulates Eric Betzig, Stefan Hell and William Moerner on winning the 2014 Nobel Prize for Chemistry. All three underscored the value of microscopy in research with their discovery of methods to achieve superresolution. The limit of optical resolution calculated by Ernst Abbe, company founder Carl Zeiss's partner, in the 19th century has [...]
Carl Zeiss Research Award Winners and Partners Receive Nobel Prize
October 10, 2014
OBERKOCHEN/Germany -- The Nobel Prize was recently awarded for medicine, physics and chemistry. Customers and partners of ZEISS are also among the winners, including former Carl Zeiss Research Award winners Shuji Nakuamura and Stefan Hell. "We are very excited that these researchers have won the Nobel Prize," says Professor Michael Kaschke, President and CEO of [...]
October 10, 2014
MR Solutions has demonstrated its world-wide presence in the preclinical MRI imaging sector at the 2014 World Molecular Imaging Congress (WMIC) in Seoul, Korea in September 2014. Being shown for the first time was MR Solutions’ new in vivo optical imaging technology, the MRS CellLIVETM system which can examine the interior of a sedated animal [...]
BioTime, Inc. Closes $31 Million Financing
October 9, 2014
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX) today announced that it has closed the equity financing it disclosed on October 3, 2014, through which BioTime received $29,425,961 and certain subsidiaries received approximately $1,558,905 from the sale of BioTime common shares. BioTime and the subsidiaries intend to use the net proceeds from their sales to [...]
October 9, 2014
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it made a technology acquisition from AbVitro Inc, a company focused on therapeutic target discovery. Roche obtained exclusive rights to a primer extension based target enrichment technology and associated patent applications filed by AbVitro. Under the terms of the agreement, AbVitro and Roche scientists will collaborate on [...]
